BMS/Celgene Post-Merger Early R&D Strategy: Partnerships Are Still Key, Vessey Says

Research and early development head Rupert Vessey, who had a similar role at Celgene, told Scrip that integration of the company’s pipeline into Bristol is nearly complete with few overlapping programs.